60 Degrees Pharmaceuticals Inc. (SXTP)
(Delayed Data from NSDQ)
$1.38 USD
+0.04 (2.99%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $1.37 -0.01 (-0.72%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth F Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
SXTP 1.38 +0.04(2.99%)
Will SXTP be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SXTP based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SXTP
Ardelyx (ARDX) Reports Q2 Loss, Tops Revenue Estimates
Harrow (HROW) Reports Q1 Loss, Lags Revenue Estimates
SXTP: What are Zacks experts saying now?
Zacks Private Portfolio Services
60 Degrees Pharmaceuticals Inc. (SXTP) Reports Q3 Loss, Misses Revenue Estimates
VAXART, INC. (VXRT) Reports Q3 Loss, Tops Revenue Estimates
OptiNose (OPTN) Reports Break-Even Earnings for Q3
Other News for SXTP
60 Degrees Pharmaceuticals (SXTP) Partners with Tulane University for Lyme Disease Research | ...
60 Degrees Pharmaceuticals and Tulane University Sign Research Agreement to Study Tafenoquine ...
60 Degrees Pharmaceuticals, Tulane University sign research agreement
12 Health Care Stocks Moving In Tuesday's Intraday Session
60 Degrees Pharmaceuticals (SXTP) Announces Public Offering Details